Amexdrug Corporation (AXRX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

axrx · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 2 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Amexdrug CorporationYou AXRX	$0M	0.66x	—	$0.00
Curative Biosciences, Inc. CBDX	$0M	N/A	—	-$0.00
Molecular Pharmacology (USA), Ltd. MLPH	$0M	N/A	—	-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Amexdrug Corporation (AXRX) measures how much investors pay for each dollar of the company's trailing earnings. AXRX's current PE ratio of 0.66x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.00.

PE Ratio = Stock Price ÷ EPS (TTM)

= $0.00 ÷ $0.00 = 0.66x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

AXRX pe ratio · 6 questions

AXRX's current PE ratio is 0.66x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via AXRX's SEC 10-K and 10-Q filings.

AXRX PE ratioWhat is AXRX PE ratioCurrent PE ratio of AXRXAXRX PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Amexdrug Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09